Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - glycine | glucose | calcium gluconate | potassium phosphate | magnesium sulfate | sodium chloride - nutrition & metabolism - calf | pigs | beef calf | boar | bovine | calf - poddy | calf - preweaning | calf - sucker | dairy calf | gilt | neonatal calf | - diarrhoea | electrolytes | absorptive | acute diarrhoea | acute intestinal catarrh | avian blackhead | bacterial enteritis | blackhead | chronic diarrhoea | coccidiosis | dietary factors | dietary upset | enteritis | feed conversion | flatulance | fluid loss | gastro-intestinal | gram negative bacteria | growth rate | k88+ serotypes of e.coli | nesting diarrhoea | non-specific irritants | poisoning | postweaning scours | prophylactic | scours | streptomycin sensitive bacteri | sulphadiazine sensitive bacter | sulphonamide sensitive bacteri | trichomoniasis | trimethoprim sensitive bacteri | white scours

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nutriceutics pty limited - disodium phosphate | chromic chloride | glycine | citric acid | glucose | calcium gluconate | potassium chloride | dipotassium phosphate | magnesium citrate | magnesium sulfate | sodium chloride - nutrition & metabolism - dog | dog - greyhound | bitch | castrate | puppy | racing greyhound - dehydration | electrolyte replacement | supplement energy needs

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - glycine (unii: te7660xo1c) (glycine - unii:te7660xo1c) - glycine 1.5 g in 100 ml - 1.5% glycine irrigation, usp is indicated for use as a urologic irrigating fluid with endoscopic instruments during transurethral procedures requiring distension, irrigation, and lavage of the urinary bladder. it may be used for lavage of an indwelling catheter to maintain patency. anuria.

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - glycine (unii: te7660xo1c) (glycine - unii:te7660xo1c) - glycine 1.5 g in 100 ml - 1.5% glycine irrigation usp is indicated as an irrigant during transurethral prostatic or bladder surgery. 1.5% glycine irrigation usp is not for injection. it is contraindicated in patients with anuria.

United States - English - NLM (National Library of Medicine)

hospira, inc. - glycine (unii: te7660xo1c) (glycine - unii:te7660xo1c) - glycine 1.5 g in 100 ml - 1.5% glycine irrigation, usp is indicated for use as irrigating fluid during transurethral prostatic resection and other transurethral surgical procedures. not for injection by usual parenteral routes. do not use in patients with anuria.

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - glycine (unii: te7660xo1c) (glycine - unii:te7660xo1c) - glycine 1.5 g in 100 ml - 1.5% glycine irrigation usp is indicated as an irrigant during transurethral prostatic or bladder surgery. 1.5% glycine irrigation usp is not for injection. it is contraindicated in patients with anuria.

United States - English - NLM (National Library of Medicine)

corepharma, llc - amphetamine sulfate (unii: 6dpv8nk46s) (amphetamine - unii:ck833kgx7e), dextroamphetamine saccharate (unii: g83415v073) (dextroamphetamine - unii:tz47u051fi), amphetamine aspartate monohydrate (unii: o1zpv620o4) (amphetamine - unii:ck833kgx7e), dextroamphetamine sulfate (unii: jj768o327n) (dextroamphetamine - unii:tz47u051fi) - amphetamine sulfate 1.875 mg - dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets are indicated for the treatment of attention deficit hyperactivity disorder (adhd) and narcolepsy. a diagnosis of attention deficit hyperactivity disorder (adhd; dsm-iv® ) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. the symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in two or more settings, e.g., school (or work) and at home. the symptoms must not be better accounted for by another mental disorder. for the inattentive type, at least six of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes; lack of sustained attention; poor listener; failure to follow through on tasks; poor organization; avoids tasks requiring sustained mental effort; loses things; easily distracted; forgetful.

United States - English - NLM (National Library of Medicine)

ucyclyd pharma inc. - sodium phenylacetate (unii: 48n6u1781g) (phenylacetic acid - unii:er5i1w795a), sodium benzoate (unii: oj245fe5eu) (benzoic acid - unii:8skn0b0mim) - sodium phenylacetate 100 mg in 1 ml - ammonul is indicated as adjunctive therapy in pediatric and adult patients for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. during acute hyperammonemic episodes, arginine supplementation, caloric supplementation, dietary protein restriction, hemodialysis, and other ammonia lowering therapies should be considered [ see warnings and precautions (5) ]. none. pregnancy category c. animal reproduction studies have not been conducted with ammonul. it is not known whether ammonul can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. thus, ammonul should be given to a pregnant woman only if clearly needed. it is not known whether sodium phenylacetate, sodium benzoate, or their conjugation products are excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when ammonul is administered to a nursing woman. ammonul has been used as a treat

United States - English - NLM (National Library of Medicine)

zydus pharmaceuticals (usa) inc. - amphetamine sulfate (unii: 6dpv8nk46s) (amphetamine - unii:ck833kgx7e), amphetamine aspartate monohydrate (unii: o1zpv620o4) (amphetamine - unii:ck833kgx7e), dextroamphetamine sulfate (unii: jj768o327n) (dextroamphetamine - unii:tz47u051fi), dextroamphetamine saccharate (unii: g83415v073) (dextroamphetamine - unii:tz47u051fi) - amphetamine sulfate 1.25 mg - dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets are indicated for the treatment of attention deficit hyperactivity disorder (adhd) and narcolepsy. a diagnosis of attention deficit hyperactivity disorder (adhd; dsm-iv® ) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. the symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in two or more settings, e.g., school (or work) and at home. the symptoms must not be better accounted for by another mental disorder. for the inattentive type, at least six of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes; lack of sustained attention; poor listener; failure to follow through on tasks; poor organization; avoids tasks requiring sustained mental effort; loses things; easily distracted; forgetful.

United States - English - NLM (National Library of Medicine)

icu medical inc. - glycine (unii: te7660xo1c) (glycine - unii:te7660xo1c) - 1.5% glycine irrigation, usp is indicated for use as irrigating fluid during transurethral prostatic resection and other transurethral surgical procedures. not for injection by usual parenteral routes. do not use in patients with anuria.